Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

Maïté Verreault(BC Cancer Agency), Marcel B. Bally(BC Cancer Agency)

PLoS ONE

March 15, 2013

10.1371/journal.pone.0059597

Cited by 28

Related Papers

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

|PLoS ONE|2013|101

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

|Breast Cancer Research|2009|73

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

|International Journal of Nanomedicine|2017|65

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

|BMC Cancer|2011|56

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

|Oncogene|2010|49